UK second place in health research
This article was originally published in Scrip
The UK remains second behind the US in international research performance in health and medical science. However it faces constant challenge from key markets in Europe as well as from China, Korea and Singapore, points out a new report from the UK's Department for Innovation, Universities and Skills (DIUS).
You may also be interested in...
Cerimon Pharmaceuticals' once-daily topical-patch formulation of the NSAID diclofenac gave significantly better average pain relief than placebo in ankle-sprain patients who carried out their daily activities in a Phase II trial, at the third day in the study.
Following a second resubmission, the Scottish Medicines Consortiumhas accepted Lilly's Alimta (pemetrexed) for restricted use within the Scottish NHS as a monotherapy for the second-line treatment of locally advanced or metastatic non-small cell lung cancer.